|
|
|
|
| Symbol(s): |
MBI.V |
| Date: |
13-Mar-13 |
| Author: |
GlobalData |
| Contributor: |
GlobalData |
| Title: |
Med BioGene Inc. (MBI) - Medical Equipment - Deals and Alliances Profile |
| Document Size: |
30 pages |
| Price: |
$250 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $250. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Med BioGene Inc. (MBI) - Medical Equipment - Deals and AlliancesProfile Summary Med BioGene Inc. (MBI) is a developmental stagelife sciences company that focuses on the development ofgenomic-based clinical laboratory diagnostic tests for cancer. Itfocuses on managing license and rights to its lead test underdevelopment, LungExpress Dx. LungExpress Dx is a prognosticgenomic-based test for early stage non-small cell lung cancer(NSCLC) that analyzes the molecular profile of the tumor in thepatient, and...
| | |
|
|
